PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsGilvetmab
Gilvetmab
Gilvetmab is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
3841 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD0022893847281194
MelanomaD00854525398153
Squamous cell carcinoma of head and neckD00007719511226134
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C806034274
CarcinomaD002277C80.023362067
Lung neoplasmsD008175C34.9021281047
Colorectal neoplasmsD0151791715529
Triple negative breast neoplasmsD0647261417529
Squamous cell carcinomaD002294719527
Breast neoplasmsD001943EFO_0003869C501016527
Renal cell carcinomaD002292EFO_00003761211824
Head and neck neoplasmsD006258711720
Ovarian neoplasmsD010051EFO_0003893C561016219
Show 34 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.991722
Pancreatic neoplasmsD010190EFO_0003860C25131219
B-cell lymphomaD016393479
SarcomaD012509377
Large b-cell lymphoma diffuseD016403C83.3346
GlioblastomaD005909EFO_0000515446
Castration-resistant prostatic neoplasmsD064129245
Non-hodgkin lymphomaD008228C85.9334
MesotheliomaD008654C45334
Microsatellite instabilityD053842144
Show 78 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelodysplastic syndromesD009190D4611
PharmacokineticsD01059911
Thoracic neoplasmsD01389911
Invasive hydatidiform moleD002820D39.211
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameGilvetmab
INNgilvetmab
Description
Gilvetmab is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL3990007
ChEBI ID
PubChem CID
DrugBank
UNII ID949NG8376D (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 60,182 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
25 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use